HA, G.; KWONG, K.; TANAKA, B.; NISHIMURA, Y.; CHONG, C. Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease? iMCD after HHV-8-associated MCD. European Journal of Case Reports in Internal Medicine, [S. l.], v. 10, n. 7, 2023. DOI: 10.12890/2023_003904. Disponível em: https://www.ejcrim.com/index.php/EJCRIM/article/view/3904. Acesso em: 3 jul. 2024.